Compagnie de Financement Foncier : Results for the 1st half

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
59
Compagnie de Financement Foncier : Results for the 1st half of 2018

Press release with effective and complete dissemination                           Paris, August 1 st , 2018

Results of Compagnie de Financement Foncier for the 1 st half of 2018

The Board of Directors of Compagnie de Financement Foncier met on August 1 st , 2018 under the chairmanship of Benoît Catel, to approve the 2018 half-year financial statements.

The real estate loan market has remained dynamic since the beginning of 2018, but has shown a slight drop due to the increase in real estate prices in the most sought-after areas and the slowdown in demand. Despite low interest rates and intense competition between credit institutions, there has been a continued fall in early repayments since the second half of 2017.

During the 1 st half of 2018, Compagnie de Financement Foncier's business activity remained in line with Crédit Foncier's strategic guidelines in close synergy with Groupe BPCE and with its own management commitments.

I. Activity of Compagnie de Financement Foncier

Issuance of obligations foncières :

  • In the 1 st half of 2018, Compagnie de Financement Foncier issued €4.2bn of obligations foncières . This volume includes private placements and three benchmarks: a ten-year €1.0bn issuance in January, a five-year €1.5bn issuance in April, and an eight-year €1.25bn issuance in May. These issuances were carried out under excellent conditions and with high subscription levels, demonstrating investor confidence in the creditworthiness of Compagnie de Financement Foncier.
  • Obligations foncières outstanding (including related payables) amounted to €62.7bn on June 30, 2018, compared with €63.4bn on December 31, 2017.

Purchases and assignment of receivables:

  • During the 1 st half of 2018, Compagnie de Financement Foncier refinanced €3.9bn of loans including related receivables, in addition to €0.2bn in financing commitments. The drop in the rate of early repayments between the end of December 2017 (16.5%) and the end of June 2018 (7.9%) limited the decline in mortgage assets on Compagnie de Financement Foncier's balance sheet.

II. Compagnie de Financement Foncier's income statement

In millions of euros 1 st half of 2018 1 st half of 2017 Change in %
Net banking income 131.7   93.4   +41.0%
Operating expenses -44.3  -64.8   -31.6%
Gross operating income   87.5   28.6 +205.9%
Cost of risk -2.5  -3.6   -30.6%
Gains or losses on long-term investments  0  7.3 n/a
Income before tax  84.9   32.3 +162.8%
Income tax -37.5  -13.2 +184.1%
Net income 47.4   19.1 +148.2%

The net banking income stood at €131.7m, up compared with the 1 st half of 2017 (€93.4m), with the net interest margin improvement partially offset by the decrease in the level of prepayment penalties on home loans.

The operating expenses accounted for €44.3m as of June 30, 2018, down by €20.5m compared with the 1 st half of 2017.

There were no net gains on long-term investments in the 1 st half of 2018, compared with €7.3m for the same period in 2017 which recorded gains on sales of international securities.

The gross operating income was €87.5m.

The cost of risk represented a €2.5m expense as of June 30, 2018, a slight improvement compared with the 1 st half of 2017 (less than 1bp of home loans to individuals).

Net income stood at €47.4m on June 30, 2018.

III. Balance sheet information

The balance sheet totaled €77.0bn as of June 30, 2018 compared with €78.4bn as of December 31, 2017, in line with Crédit Foncier group's strategy to reduce the size of its balance sheet.

Doubtful loans stood at €1.6bn as of June 30, 2018 compared with €1.4bn as of December 31, 2017 and were concentrated for over 99.5% on home loans to individuals.

IV. Prudential information

Although exempted from regulatory requirements concerning solvency ratios, Compagnie de Financement Foncier calculates a Common Equity Tier One ratio for indicative purposes. As of June 30, 2018, this ratio remained well above the minimum thresholds specified in CRR regulation 575/2013.

Furthermore, Compagnie de Financement Foncier continued to carry out an extremely prudent liquidity management and had a consistent level of cash deposited with the Bank of France as of June 30, 2018.

Finally, in accordance with the law applicable to sociétés de crédit foncier , Compagnie de Financement Foncier must maintain a coverage ratio (equal to the ratio between weighted assets and privileged debt) greater than 105% at all times. As of March 31, 2018, this ratio was 114.3%.

V. Repositioning project of Compagnie de Financement Foncier

On June 26, 2018, Crédit Foncier and the Groupe BPCE announced a project to integrate the activities and skills of Crédit Foncier within Groupe BPCE entities. This project is subject to information-gathering and consultation between the employee representative bodies of Crédit Foncier and the group entities concerned and to approval by the competent corporate bodies. Once approval is obtained from these bodies, subject to any changes and if this project is implemented, Compagnie de Financement Foncier would remain a strategic subsidiary of Groupe BPCE, under the affiliation scheme, thus joining the Groupe BPCE solidarity mechanism.  Beyond the guarantees provided by the regulation applicable to sociétés de crédit foncier , holders of obligations foncières would therefore continue to benefit from this additional guarantee.

Appendix

***

Unless otherwise specified, the financial information included in this press release is estimated and taken from the financial statements of Compagnie de Financement Foncier. Those statements include the individual accounts and related explanatory notes, prepared in compliance with French accounting standards and the applicable BPCE standards.

At the date of this press release, the audit of the half-year financial statements by the Statutory Auditors ("Commissaires aux comptes") is still in progress.

Compagnie de Financement Foncier is a credit institution company registered as a specialized credit institution and a société de crédit foncier (a French legal covered bonds issuer), affiliate of BPCE and fully-owned by Crédit Foncier.

Regulated information is available on our website www . foncier.fr under "Financial communication/Regulated information".

Contacts: Investor relations Email: ir@foncier.fr Tel.: +33 (0) 1 57 44 85 71

                 

Attachment

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 0

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 2

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 0

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 3

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading

Top 5 Most Recently Viewed Articles

Conformal Coatings Market Set for Significant Growth by 2032

Updated Category News Views 233

The conformal coatings market surged ahead with projections showing it could reach USD 1.7 billion by 2032. This translates into a compound annual growth rate (CAGR) of 5.7% from 2024 to 2032, driven primarily by advancements in electronic protection technologies. Traders had better keep their eyes peeled—this ain't just a bump; it's a substantial shift. What’s...

Continue Reading
Japanese Mobile Battery Industry Forecasts Significant Growth

Updated Category News Views 122

Japan Mobile Battery Market Overview The mobile battery market in Japan is witnessing significant growth, with a valuation of JPY 207.96 billion in 2024 and projected to escalate to JPY 358.97 billion by 2033, marking a compound annual growth rate (CAGR) of 6.48% from 2025 to 2033. This growth trajectory highlights not only increasing consumer demands but also rapidly...

Continue Reading
Givastomig: A Promising Player in Gastric Cancer Therapy

Updated Category News Views 74

Givastomig's Advances in Gastric Cancer Research I-Mab (NASDAQ: IMAB), a biotech firm focused on developing cancer immunotherapies, recently presented exciting results from its Phase 1 clinical trial involving givastomig. This innovative bispecific antibody immunostimulant was unveiled at a prominent medical conference, demonstrating its effectiveness in treating advanced...

Continue Reading
Rani Therapeutics Partners with Chugai for Drug Delivery Breakthrough

Updated Category News Views 245

Rani Therapeutics Engages with Chugai Pharmaceutical Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) recently announced a significant collaborative effort with Chugai Pharmaceutical Co., Ltd., resulting in an enthusiastic response from investors. This collaboration aims to utilize Rani's innovative RaniPill oral drug delivery system alongside Chugai's experimental...

Continue Reading
Revizto's Brand Revamp: A Bold Step Towards Future Growth

Updated Category News Views 142

Revizto Introduces a Fresh Brand Identity As project complexities continue to rise in the construction industry, Revizto is making important modifications to its public image. The renowned collaboration platform, specifically designed for the Architecture, Engineering, Construction, and Operations (AECO) sectors, recently unveiled its refreshed brand identity,...

Continue Reading